by NavigoProteins | Feb 8, 2021 | Press
WALTHAM, Mass., and HALLE (Saale), Germany – February 8, 2021 – Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), a premier protein engineering company specializing in...
by NavigoProteins | Aug 4, 2020 | Press
HALLE (Saale), Germany, and WALTHAM, Mass. – October 1, 2020 – Navigo Proteins GmbH (“Navigo”), a premier protein engineering company specializing in novel affinity ligand development, and Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on...
by NavigoProteins | Apr 27, 2018 | Press
WALTHAM, MA – June 27, 2018– Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH (“Navigo”) for the advancement of exclusive novel affinity ligands used in...
by NavigoProteins | Jan 12, 2017 | Press
Halle (Saale), Germany – 3rd Feb 2017 – Scil Proteins GmbH, the expert protein engineering company for affinity ligands and targeted carriers, today announced that UV-Cap GmbH & Co KG, Ravensburg, has acquired 100% of the shares of Scil Proteins from Bionet...
by NavigoProteins | Jan 3, 2016 | Press
Garching, Germany and Halle, Germany – 24 March 2016 – ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, and Scil Proteins, the expert company in Affilin®-based protein engineering, today announced they have entered into a...
Recent Comments